CITIUS PHARMACEUTICALS INC (CTXR)
US17322U2078 - Common Stock
| TTM (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.18M | -32.54M | -33.64M | -23.05M | -17.55M | |||
| Depreciation Amortization | 3.25K | 2.67K | 0.00 | 0.00 | 0.00 | |||
| Income Taxes - Deferred | 580.00K | 576.00K | 580.00K | N/A | N/A | |||
| Change In Working Capital | -1.62M | -4.01M | 240.00K | -2.72M | -870.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 8.85M | 6.91M | 4.46M | 1.52M | 1.48M | |||
| OPERATING CASH FLOW | -30.38M | -29.06M | -28.36M | -24.25M | -16.93M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -40.01M | 0.00 | |||
| Other Investing Activity | N/A | 0.00 | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | 0.00 | 0.00 | -40.01M | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -170.00K | 160.00K | |||
| Stock Issued/Repurchased | N/A | 13.83M | 0.00 | 102.19M | 22.73M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 18.45M | N/A | |||
| FINANCING CASH FLOW | N/A | 13.83M | 0.00 | 120.47M | 22.90M | |||
| CHANGE IN CASH | -16.55M | -15.23M | -28.36M | 56.21M | 5.97M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -30.38M | -29.06M | -28.36M | -24.25M | -16.93M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -40.01M | 0.00 | |||
| FREE CASH FLOW | -30.38M | -29.06M | -28.36M | -64.26M | -16.93M | |||
All data in USD